Therapy with cardiopoietic stem cells has been shown to improve heart health for people suffering from heart failure, a multi-centre clinical trial has shown.The Mayo Clinic say the trial, which was the first application in humans of lineage-guided stem cells for targeted regeneration of a failing organ, will pave the way to the development of next generation regenerative medicine therapies.
The trial results are detailed in an article entitled “C-CURE Multicenter Trial: Lineage Specified Bone Marrow Derived Cardiopoietic Mesenchymal Stem Cells For Treatment of Ischemic Cardiomyopathy”, published in the Journal of the American College of Cardiology.
The clinical trial was designed to assess feasibility and safety of cardiopoietic mesenchymal stem cells (MSC) in ischaemic heart failure. The...